An Analysis of Platelet Rich Plasma Variables Using the Arthrex Angel System


About this study

The purpose of this study is to evaluate the cellular composition of PRP produced by the Arthrex Angel System.

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Healthy men and women between the ages of 18-100 who have had or are scheduled to have PRP injections using the Arthrex Angel system at the Mayo Clinic Sports Medicine Center.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status

Rochester, Minn.

Mayo Clinic principal investigator

Jacob Sellon, M.D.

Closed for enrollment

More information


Publications are currently not available

Mayo Clinic Footer